Search Results for keywords:"Director's Order

The Bureau of Land Management (BLM), under the Interior Department, has issued an amended order to manage certain public lands in Alaska. Originally set by Public Land Order (PLO) 7899 on January 19, 2021, the lands will now remain closed until April 19, 2021, to allow for orderly administration. On that date, the lands will be open for activities such as mining and leasing, following federal land laws and procedures. Any breaches of these conditions before this date will not be recognized by the United States government.

The Environmental Protection Agency (EPA) issued a notice denying a petition to overturn a Consent Agreement and Proposed Final Order involving the Frederick-Winchester Service Authority and Frederick County Sanitation Authority. This decision was made after reviewing a petition that claimed false statements were made regarding economic benefits and pollution control practices by the respondents. The EPA determined that these statements were not materially false and did not warrant setting aside the order or holding a hearing. The case details, including the order, are accessible online for public review.

OSHA has announced that Ballard Marine Construction has applied for a Permanent Variance and Interim Order to work under compressed air in constructing the Suffolk County Outfall Tunnel in New York. The variance would allow Ballard to use different decompression methods than those specified by OSHA's existing standards, relying instead on the 1992 French Decompression Tables and other safety measures like the use of a hyperbaric operations manual and a detailed training program for workers. OSHA has granted an Interim Order allowing the use of these methods temporarily and is seeking public comments before deciding whether to grant a permanent variance. The agency emphasizes that these measures aim to ensure worker safety and are backed by past successful variances for similar projects.

The Food and Drug Administration (FDA) issued a permanent debarment order against Alec Burlakoff under the Federal Food, Drug, and Cosmetic Act. Burlakoff was convicted of a felony involving illegal activities with a drug called SUBSYS while working at Insys Therapeutics. His actions included bribing doctors to prescribe the drug, often to patients who did not have cancer. As a result, Burlakoff is banned from providing services related to drug product applications, and there are penalties for any approved drug product applications that employ him during this period.

The Executive Office of the President issued Executive Order 14016, revoking Executive Order 13801, which was about expanding apprenticeships in America. The order instructs government officials to review and potentially rescind any related policies or positions created under the previous order, in line with the law. It clarifies that this change should not interfere with the legal authority of government agencies or impact budgetary processes. Additionally, it states that the order does not create any legal rights for parties against the U.S. government.

President Biden issued Executive Order 13983, which revokes Executive Order 13770. This order, initially put in place on January 28, 2017, required ethics commitments from Executive Branch appointees. The revocation is effective as of noon on January 20, 2021, meaning that neither current nor former employees are bound by those commitments after this time. The order also clarifies that it should not interfere with existing legal authority or create new legal rights.

The Food and Drug Administration (FDA) has issued an order under the Federal Food, Drug, and Cosmetic Act to debar Harpreet Singh for 10 years from importing any drugs into the United States. This decision follows Mr. Singh's conviction for several felonies, including conspiring to distribute controlled substances like cathinone, tapentadol, tramadol, and carisoprodol, fraudulent importation and transportation of goods, conspiracy to launder money, and conspiracy to obstruct justice. The FDA based the debarment on Mr. Singh’s illegal activities related to the importation of misbranded drugs and money laundering, along with his failure to request a hearing to contest the debarment. This order takes effect on March 13, 2025.

The Food and Drug Administration (FDA) has issued an order permanently banning Jerrod Nichols Smith from providing services related to drug product applications. This decision follows his conviction on multiple felony counts of mail fraud and obstruction of justice, connected with the unlawful distribution and misrepresentation of prescription drugs. Smith's company, Cumberland Distribution, was involved in distributing drugs illegally obtained from unlicensed sources, leading to significant profit from falsified documents and drug mislabeling. After being notified, Smith did not respond or request a hearing, resulting in his debarment which prohibits him from engaging in drug product services.

The Bureau of Industry and Security (BIS), part of the U.S. Department of Commerce, issued a temporary order to deny export privileges for 180 days to several entities, including Kirill Gordei and Apelsin Logistics Inc. This decision was made because they were involved in shipping U.S. goods to Russia, bypassing U.S. export rules using false documents in collaboration with other companies. The investigation revealed significant and deliberate violations, such as transshipping a Mass Spectrometer and other goods to Russia without the necessary licenses. The order aims to prevent further violations and serves as a warning to others to avoid transactions with these entities.

The Drug Enforcement Administration (DEA) has revoked the DEA registration of Dr. Victor Augusto Silva from Tampa, Florida, due to his failure to comply with federal and state laws regarding controlled substances. The DEA found that Dr. Silva allowed an unauthorized individual to use his registration to issue prescriptions for controlled substances, which is against the law. As Dr. Silva did not adequately respond to the charges or demonstrate he can be trusted with prescribing controlled substances, the DEA determined his continued registration would not serve the public interest. As a result, his registration was revoked, and any pending applications for registration in Florida were denied.